NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Emerging Infections; Harrison PF, Lederberg J, editors. Antimicrobial Resistance: Issues and Options: Workshop Report. Washington (DC): National Academies Press (US); 1998.

Cover of Antimicrobial Resistance

Antimicrobial Resistance: Issues and Options: Workshop Report.

Show details

Forum on Emerging Infections

JOSHUA LEDERBERG1 (Chair), Sackler Foundation Scholar, The Rockefeller University, New York

VINCENT I. AHONKHAI, Vice President and Director, Anti-Infectives and Biologicals, SmithKline Beecham Corporation, Collegeville, Pennsylvania

STEVEN J. BRICKNER, Manager of Medicinal Chemistry, Central Research Division, Pfizer, Inc., Groton, Connecticut

GAIL H. CASSELL,2 Vice President for Infectious Diseases Research, Drug Discovery Research, and Clinical Investigation, Eli Lilly & Company, Indianapolis

GORDON H. DEFRIESE,2 Director and Professor of Social Medicine, Epidemiology, Health Policy, and Administration, Sheps Center for Health Services Research, University of North Carolina, Chapel Hill

NANCY CARTER FOSTER,3 Director, Program for Emerging Infections and HIV/AIDS, Department of State, Washington, D.C.

RENU GUPTA, Senior Medical Director, Infectious Diseases, Bristol-Myers Squibb Company, Princeton, New Jersey

MARGARET A. HAMBURG,2 Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Washington, D.C.

DIETER HINZEN, Professor and Head of Preclinical Research, F. HoffmannLaRoche, A.G., Basel, Switzerland

JAMES M. HUGHES,3 Assistant Surgeon General, and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta

J. STANLEY HULL, Vice President, Global Commercial Development, Glaxo Wellcome, Research Triangle Park, North Carolina

SAMUEL L. KATZ,2 Chairman of the Board, Burroughs Wellcome Fund, and Wilburt C. Davison Professor, Department of Pediatrics, Duke University Medical Center

KENNETH W. KIZER,3 Under Secretary for Health, Veterans Health Administration, Department of Veterans Affairs, Washington, D.C.

WILLIAM KOHLBRENNER, Director, Antiviral Research, Abbott Laboratories, Abbott Park, Illinois

JOHN R. LaMONTAGNE,3 Deputy Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

CARLOS LOPEZ, Executive Director, Infectious Disease Research, Eli Lilly Research Laboratories, Indianapolis

STEPHEN S. MORSE, Assistant Professor of Epidemiology, Columbia University School of Public Health, and Defense Advanced Research Projects Agency/Defense Sciences Office, Washington, D.C.

SOLOMON MOWSHOWITZ, Vice President, Research and Development, Applied Microbiology, Inc., Tarrytown, New York

STUART L. NIGHTINGALE,3 Associate Commissioner for Health Affairs, Food and Drug Administration, Department of Health and Human Services, Rockville, Maryland

MICHAEL T. OSTERHOLM, State Epidemiologist and Chief, Acute Disease Epidemiology Section, Minnesota Department of Health, Minneapolis

DAVID M. SHLAES, Vice President, Infectious Disease Research, Wyeth-Ayerst Research, Pearl River, New York

JOHN D. SIEGFRIED, Deputy Vice-President, Science and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, D.C.

P. FREDERICK SPARLING, Chair of Medicine, University of North Carolina, Chapel Hill, and President, Infectious Diseases Society of America, Washington, D.C.

Liaisons to the Forum

BARRY R. BLOOM,2 Investigator, Howard Hughes Medical Institute, and Albert Einstein College of Medicine, Yeshiva University, Hastings-on Hudson, New York

ENRIQUETA C. BOND, President, Burroughs Wellcome Fund, Morrisville, North Carolina

GARY CHRISTOPHERSON, Senior Advisor, Health Affairs, Department of Defense, Washington, D.C.

MICHAEL HUGHES, Office of the Undersecretary, Veterans Health Administration, Department of Veterans Affairs, Washington, D.C.

STEPHANIE JAMES, Parasitology and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

C. MICHELLE LIMOLI, Special Assistant to the Director, Office of International Affairs, Food and Drug Administration, Rockville, Maryland

STEPHEN M. OSTROFF, Acting Deputy Director, and Associate Director for Epidemiologic Science, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta

GARY ROSELLE, Program Director for Infectious Disease, Veterans Administration, Cincinnati, Ohio

FRED TENOVER, Chief, Nosocomial Pathogens Laboratory Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta

Study Staff

JONATHAN R. DAVIS, Senior Program Officer (from February 1998)

POLLY F. HARRISON, Senior Program Officer (to January 1998)

GRETCHEN G. KIDDER, Research Assistant (to February 1998)

CHRISTINA THACKER, Research/Project Assistant

Division Staff

LINDA DEPUGH, Administrative Assistant

ANDREW M. POPE, Acting Director (from January 1998)

VALERIE P. SETLOW, Division Director (to December 1997)

JAMAINE TINKER, Financial Associate

Member, Institute of Medicine and National Academy of Sciences.

Member, Institute of Medicine.

Ex-officio member.

Footnotes

1

Member, Institute of Medicine and National Academy of Sciences.

2

Member, Institute of Medicine.

3

Ex-officio member.

Copyright © 1998, National Academy of Sciences.
Bookshelf ID: NBK100883
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (808K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...